EX-99.1
5
lsmg-ex99_1.htm
PRESS RELEASE, DATED DECEMBER 30, 2021.
Exhibit
99.1
Lode-Star
Mining, INC
1
East Liberty Street
Suite
600
Reno,
NV 89501
Tel
-1-775-234-5443
Fax
- 1-775-335-1041
info@lode-starmining.com
Sapir
Pharmaceuticals Acquisition
Reno,
December, 30 2021 - Lode-Star Mining Inc. (OTCQB:LSMG) is pleased to announce that it has acquired from Sapir Pharmaceuticals,
Inc. all of the assets used in connection with the proprietary stabilized formulation of the E
pigallocatechin-gallate
(EGCG)
molecule for further pharmaceutical development. The molecule is an antioxidant polyphenol with a variety of potential
profound health benefits.
The
consideration paid by Lode-Star for these assets was 1,000,000 shares of Series A Preferred Stock valued at $1.00 per share. Sapir
has the right to convert each preferred share to 450 shares of common stock. Each share of preferred votes as 450 shares per one
share of common stock.
Contact
for Lode-Star Mining, Inc.
Mark
Walmesley
President
Lode-Star
Mining Inc.
phone
: (775) 234-5443
e-mail
:
markw@lode-starmining.com
Forward
Looking Statements
This
news release may contain forward-looking statements that involve known and unknown risks, uncertainties and other factors which
may cause LSMG's actual results, performance or achievements to be materially different from any future results, performance or
achievements expressed or implied by the forward looking statements. Forward-looking statements reflect LSMG's current views with
respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, investors
should not place undue reliance on these forward-looking statements. Except as required by law, LSMG assumes no obligation to
update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated
in any forward-looking statements, even if new information becomes available in the future.

EX - 99 . 1 5 lsmg - ex99 _ 1 . htm PRESS RELEASE , DATED DECEMBER 30 , 2021 . Exhibit 99 . 1 Lode - Star Mining , INC 1 East Liberty Street Suite 600 Reno , NV 89501 Tel - 1 - 775 - 234 - 5443 Fax - 1 - 775 - 335 - 1041 info@lode-starmining.com Sapir Pharmaceuticals Acquisition Reno , December , 30 2021 - Lode - Star Mining Inc . ( OTCQB : LSMG ) is pleased to announce that it has acquired from Sapir Pharmaceuticals , Inc . all of the assets used in connection with the proprietary stabilized formulation of the E pigallocatechin - gallate ( EGCG ) molecule for further pharmaceutical development . The molecule is an antioxidant polyphenol with a variety of potential profound health benefits . The consideration paid by Lode - Star for these assets was 1,000,000 shares of Series A Preferred Stock valued at $ 1.00 per share . Sapir has the right to convert each preferred share to 450 shares of common stock . Each share of preferred votes as 450 shares per one share of common stock . Contact for Lode - Star Mining , Inc . Mark Walmesley President Lode - Star Mining Inc . phone : ( 775 ) 234 - 5443 e - mail : markw@lode-starmining.com Forward Looking Statements This news release may contain forward - looking statements that involve known and unknown risks , uncertainties and other factors which may cause LSMG 's actual results , performance or achievements to be materially different from any future results , performance or achievements expressed or implied by the forward looking statements . Forward - looking statements reflect LSMG 's current views with respect to future events and are based on assumptions and subject to risks and uncertainties . Given these uncertainties , investors should not place undue reliance on these forward - looking statements . Except as required by law , LSMG assumes no obligation to update any forward - looking statements publicly , or to update the reasons actual results could differ materially from those anticipated in any forward - looking statements , even if new information becomes available in the future .
O O O O O O O O O O O O O O O O O O O O O O O O O O B-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Parties.ACQUIRED_COMPANY I-Parties.ACQUIRED_COMPANY O O O O O O O O B-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY I-Parties.BUYING_COMPANY O O O O O O O O O O O O O O B-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY I-Parties.SELLING_COMPANY O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O